Cargando…
Structure-guided design of a potent Clostridioides difficile toxin A inhibitor
Crystal structures of camelid heavy-chain antibody variable domains (V(H)Hs) bound to fragments of the combined repetitive oligopeptides domain of Clostridioides difficile toxin A (TcdA) reveal that the C-terminus of V(H)H A20 was located 30 Å away from the N-terminus of V(H)H A26. Based on this obs...
Autores principales: | Hussack, Greg, Rossotti, Martin A., van Faassen, Henk, Murase, Tomohiko, Eugenio, Luiz, Schrag, Joseph D., Ng, Kenneth K.-S., Tanha, Jamshid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909335/ https://www.ncbi.nlm.nih.gov/pubmed/36778856 http://dx.doi.org/10.3389/fmicb.2023.1110541 |
Ejemplares similares
-
Corrigendum: Structure-guided design of a potent Clostridioides difficile toxin A inhibitor
por: Hussack, Greg, et al.
Publicado: (2023) -
Neutralization of Clostridium difficile toxin B with V(H)H-Fc fusions targeting the delivery and CROPs domains
por: Hussack, Greg, et al.
Publicado: (2018) -
Toxin-Specific Antibodies for the Treatment of Clostridium difficile: Current Status and Future Perspectives (†)
por: Hussack, Greg, et al.
Publicado: (2010) -
An update on antibody-based immunotherapies for Clostridium difficile infection
por: Hussack, Greg, et al.
Publicado: (2016) -
Application of Assisted Design of Antibody and Protein Therapeutics (ADAPT) improves efficacy of a Clostridium difficile toxin A single-domain antibody
por: Sulea, Traian, et al.
Publicado: (2018)